OppenheimerFunds Inc. lessened its stake in shares of Anthem Inc (NYSE:ANTM) by 1.3% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,464,719 shares of the company’s stock after selling 33,635 shares during the quarter. Anthem comprises about 0.9% of OppenheimerFunds Inc.’s investment portfolio, making the stock its 15th biggest position. OppenheimerFunds Inc. owned about 0.96% of Anthem worth $707,325,000 as of its most recent filing with the SEC.
A number of other large investors also recently made changes to their positions in ANTM. Prime Capital Investment Advisors LLC purchased a new position in shares of Anthem in the 4th quarter worth $28,000. Destination Wealth Management purchased a new position in Anthem in the first quarter valued at about $31,000. Lee Financial Co purchased a new position in Anthem in the first quarter valued at about $32,000. Laurel Wealth Advisors LLC purchased a new position in Anthem in the fourth quarter valued at about $36,000. Finally, Liberty Wealth Management LLC purchased a new position in Anthem in the first quarter valued at about $36,000. Hedge funds and other institutional investors own 87.12% of the company’s stock.
Several research analysts have commented on ANTM shares. Citigroup raised Anthem from a “neutral” rating to a “buy” rating and set a $325.00 price objective on the stock in a research report on Friday, May 10th. UBS Group started coverage on Anthem in a research report on Tuesday, April 23rd. They issued a “buy” rating and a $294.00 price objective on the stock. Cantor Fitzgerald reaffirmed a “buy” rating and set a $360.00 target price on shares of Anthem in a research report on Sunday, April 21st. Barclays set a $338.00 target price on Anthem and gave the stock a “buy” rating in a research report on Friday, March 8th. Finally, Zacks Investment Research raised Anthem from a “hold” rating to a “buy” rating and set a $293.00 target price on the stock in a research report on Thursday, May 16th. Two investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $324.87.
NYSE:ANTM traded down $0.21 during mid-day trading on Friday, reaching $282.21. The stock had a trading volume of 2,629,200 shares, compared to its average volume of 1,848,023. The stock has a market cap of $71.61 billion, a P/E ratio of 17.76, a price-to-earnings-growth ratio of 0.98 and a beta of 0.74. Anthem Inc has a 1-year low of $227.16 and a 1-year high of $317.99. The business has a 50 day simple moving average of $278.11. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.58.
Anthem (NYSE:ANTM) last issued its earnings results on Wednesday, April 24th. The company reported $6.03 EPS for the quarter, beating the Zacks’ consensus estimate of $5.86 by $0.17. The company had revenue of $24.39 billion during the quarter, compared to the consensus estimate of $24.31 billion. Anthem had a return on equity of 14.99% and a net margin of 4.23%. Anthem’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.41 earnings per share. As a group, analysts predict that Anthem Inc will post 19.29 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 10th were issued a dividend of $0.80 per share. The ex-dividend date was Friday, June 7th. This represents a $3.20 dividend on an annualized basis and a dividend yield of 1.13%. Anthem’s dividend payout ratio (DPR) is presently 20.14%.
Anthem Company Profile
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Further Reading: Outstanding Shares
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.